曲格列汀

Trelagliptin

未知生产厂商

Trelagliptin is a dipeptidyl peptidase-4 inhibitor indicated in the control of diabetes mellitus.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Trelagliptin is a dipeptidyl peptidase-4 inhibitor indicated in the control of diabetes mellitus.

适应症

用于治疗2型糖尿病。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Crystal form F of trelagliptin and preparation method thereof
US 12264145 B2申请人: UNIV GUANGDONG TECHNOLOGY优先权: 2022
CN
US
2 件公开
KEY AMINO ACID BASED ON PROTEIN-DRUG INTERACTIONS INDUCED NEW CRYSTAL FORMS OF TRELAGLIPTIN AND PREPARATION METHODS THEREOF
US 20250163018 A1申请人: UNIV GUANGDONG TECHNOLOGY优先权: 2024
CN
US
2 件公开
New solid forms of trelagliptin and manufacturing method and purpose thereof
CN 104003975 A申请人: SICHUAN HAISCO PHARMACEUTICAL CO LTD优先权: 2013
CN
2 件公开
Novel high-purity trelagliptin crystal form and preparation thereof
CN 111440145 A申请人: SHANGHAI INST PHARMACEUTICAL IND优先权: 2014
CN
2 件公开
一种曲格列汀及其盐的制备方法
CN 108794448 B申请人: 四川科伦药物研究院有限公司优先权: 2015
CN
2 件公开
曲格列汀半琥珀酸盐的晶体及其制备方法和药物组合物
CN 105228988 B申请人: 杭州普晒医药科技有限公司优先权: 2014
CN
种适合工业化的高纯度琥珀酸曲格列汀的制备方法
CN 105315256 B申请人: 广州朗圣药业有限公司优先权: 2014
CN
New trelagliptin preparation process
CN 105418580 A申请人: SHANGHAI INST PHARMACEUTICAL IND优先权: 2014
CN
New crystal forms of trelagliptin, and preparation methods and application of crystal forms
CN 105524041 A申请人: SICHUAN HAISCO PHARMACEUTICAL CO LTD优先权: 2014
CN
一种制备曲格列汀的方法
CN 105524042 B申请人: 重庆医药工业研究院有限责任公司优先权: 2014
CN

药物

曲格列汀

概览

适应症

相关疾病

专利